CCO ציבורי
[search 0]
עוד
Download the App!
show episodes
 
The New CCO podcast from Page tells stories that explore the evolution of the CCO. From culture change to digital transformation to corporate purpose, we focus on the issues that matter to today's communications leaders. Page is the world’s premier membership organization for chief communications officers, PR agency CEOs and educators who seek to enrich the profession and improve corporate reputation management.
  continue reading
 
C
CCOHS Podcasts
Series avatar that links to series pageSeries avatar that links to series page

1
CCOHS Podcasts

Canadian Centre for Occupational Health and Safety (CCOHS)

Unsubscribe
Unsubscribe
חודשי
 
CCOHS produces monthly podcasts on a wide variety of topics related to workplace health and safety. Each episode is designed to keep you current with information, tips and insights into the health, safety and well-being of working Canadians. You can download the audio segment to your computer or MP3 player and listen to it at your own convenience.!
  continue reading
 
Updates on new data and best practices in patient care across a wide variety of psychiatric and neurological illnesses from Clinical Care Options. Gain a deeper understanding and practical clinical insights on topics ranging from bipolar depression to Parkinson’s disease psychosis. Select episodes available for CME/CE credit.
  continue reading
 
r
radio sindical CCOO
Series avatar that links to series pageSeries avatar that links to series page

1
radio sindical CCOO

l'alancantí-les marines

Unsubscribe
Unsubscribe
חודשי
 
Este programa tiene como objetivo acercar la realidad de la acción sindical a un número cada vez mayor de personas, de manera que la ciudadanía cuente con información directa y de primera mano sobre esta actividad. Se desarrollará tanto la faceta más laboral del sindicato (información sobre conflictos, convenios, salud laboral, igualdad de oportunidades, negociación colectiva, resolución de dudas laborales,...) como su papel más sociopolítico (movilización social, relación con el tejido asoc ...
  continue reading
 
Loading …
show series
 
In this episode, Jennifer Green, MD, and Carol Hatch Wysham, MD, break down the latest headlines on incretin-based therapies and how to address these topics with patients. Their discussion includes: Beneficial effects beyond glycemic control Adverse events and how to manage them Non- or partial responders and the importance of setting expectations …
  continue reading
 
At our 2023 Page Annual Conference, Dahabo Ahmed-Omer, CEO of Black North, joined a panel to share her experiences as a CEO and as a black, Muslim woman in Canada as well as actionable, candid advice on having tough conversations on DEI. If your organization’s DEI efforts have waned or are being impacted by the recent wave of anti-DEI sentiment, le…
  continue reading
 
In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including: Current therapies Studies 108 and 110: Factors Linked With Lack of Virologic Suppression After 8 Yr of TAF or TDF Kaiser Permanente Northern California: HCC or Death With TDF vs ETV for Chronic Hepatitis B Early vs Late Postpartum Cessation …
  continue reading
 
Dr. Heather O’Reilly (nee Johnston) from McMaster University discusses the connection between musculoskeletal disorders and psychological factors, and what workplaces and workers can do to limit risks for injuries. Released: February 1, 2024 File Size: 10 MB Length: 17:40 minutes ------------------------- « Musculoskeletal Disorders and Mental Heal…
  continue reading
 
In this episode, LaRon E. Nelson, PhD, RN, FNP, FNAP, FNYAM, FAAN, discusses the role that healthcare professionals (HCPs) may be playing in their patients’ pre-exposure prophylaxis (PrEP) persistence and strategies to modify their approach to encourage persistence, from Clinical Care Options (CCO), including: Racial disparities in the PrEP care co…
  continue reading
 
In this episode, Nancy Reau, MD, and her patient discuss opportunities to optimize care for people living with hepatitis B virus and hepatitis delta virus, including: The importance of patient education along the care continuum Ensuring smooth transitions of care and communication between medical teams Screening hepatitis delta in persons with chro…
  continue reading
 
In this episode, David Saunders discusses the value of nonstigmatizing discussions between people using HIV pre-exposure prophylaxis (PrEP) and healthcare professionals, including: Encouraging accountability to individualize adherence strategies and improve persistence to PrEP Reducing stigma, discrimination, and prejudice in healthcare settings to…
  continue reading
 
In this episode, Sarah M. Wood, MD, MS, discusses data and recommendations for long-acting pre-exposure prophylaxis (PrEP) as a strategy to support PrEP persistence and engagement for adolescents, including: The PrEP care continuum for adolescents System barriers to PrEP coverage and privacy concerns for adolescents The benefits and challenges of s…
  continue reading
 
With all the walking, standing, and working workers do on their feet, they can be exposed to potential injury. In winter, cold weather afflictions like frostbite, chilblains, and trench foot can cause painful and sometimes serious consequences. Tune in to this CCOHS podcast to earn more about the harm that working in cold weather can cause feet, an…
  continue reading
 
À tellement marcher, être debout et travailler sur leurs deux pieds, les travailleurs les exposent à des blessures potentielles. En hiver, les maux liés au temps froid comme les gelures, les engelures et le pied de tranchée peuvent avoir des conséquences douloureuses et parfois graves. Ne manquez pas ce balado du CCHST pour en apprendre davantage s…
  continue reading
 
In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including: Current Advisory Committee on Immunization Practices recommendations Risk factors associated with severe RSV disease, including RSV-related hospitalizations Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit fro…
  continue reading
 
The third and final episode in a 3-part series covers the safety profile of and considerations for managing adverse events associated with HER3-targeted antibody–drug conjugates, including patritumab deruxtecan (HER3-DXd) and others, in the setting of lung cancer. Presenters in this series include: Rebecca S. Heist, MD, MPH Associate Professor of M…
  continue reading
 
This second episode in a 3-part series on HER3-targeted agents in NSCLC covers current clinical trials with HER3-targeted therapy, including: Recent data on patritumab deruxtecan (HER3-DXd) in the HERTHENA-Lung01 trial The EGFRxHER3 bispecific antibodies BL-B01D1 and izalontamab The HER2xHER3 bispecific antibody zenocutuzumab The HER3-targeted anti…
  continue reading
 
This first episode in a 3-part series tackles the role of HER3 in cancer, specifically in NSCLC, and how HER3 can be effectively targeted with ADCs. Presenters in this series include: Rebecca S. Heist, MD, MPH Associate Professor of Medicine Harvard Medical School Medical Oncology Massachusetts General Hospital Boston, Massachusetts Helena Yu, MD A…
  continue reading
 
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screen…
  continue reading
 
In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screen…
  continue reading
 
In this episode, Tavell L. Kindall, PhD, DNP, ARNP, FNP-BC, AACRN, AAHIVS, FAANP, and Anne Teitelman, PhD, FNP-BC, FANNP, FAAN, discuss key PrEP considerations for advanced practice providers in primary care settings, including: The importance of having PrEP navigators to help with logistics and be a point of contact for patients Where to find educ…
  continue reading
 
In this podcast episode, Mark Brennan-Ing, PhD, and Nina I. Martinez discuss mental health challenges in people living with HIV and much-needed strategies to overcome these challenges to optimize engagement in HIV care, including: The increased rates of mental health disorders and substance use among people living with HIV How mental health disorde…
  continue reading
 
In this podcast episode, Isolde Butler, MD, MPH, a healthcare professional caring for people living with HIV, and Marissa Gonzalez, an individual living with HIV, discuss strategies to improve healthcare professionals’ competencies in delivering optimal HIV care from the start to better support patients in overcoming barriers to sustained care enga…
  continue reading
 
In this podcast episode, Babafemi Taiwo, MBBS, and Vincent Crisostomo discuss the evolving treatment landscape for aging people living with HIV, encompassing the clinical and external resources necessary to support physical and psychosocial health. The topics discussed include: • Mindful prescribing and understanding the impact an HIV diagnosis can…
  continue reading
 
In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including: Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-Pocket Offering PrEP to everyone who receives PEP Currently recommended …
  continue reading
 
During the 2023 American Association for the Study of Liver Diseases conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-δ agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholic acid and …
  continue reading
 
In this episode, Dr Tavell Kindall and Jona Tanguay discuss actionable strategies for advanced practice providers to increase the frequency at which PrEP is offered and initiated in primary care settings. Topics covered include: Available training resources on how to offer PrEP in primary care Affordable, accessible PrEP options, including patient …
  continue reading
 
In this third of 3 episodes, global HIV experts and advocates discuss the current status of HIV cure research, including key concepts to understand and communicate when counselling patients, colleagues, and the broader community on HIV cure: Latest understanding of the viral reservoir New insights and questions on the best timing for cure intervent…
  continue reading
 
In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including: Burden of CRE infections in the United States Mechanisms of resistance Changing epidemiology Use of rapid diagnostic tests IDSA guidance recommendations, including supporting data Approach to designing…
  continue reading
 
In this episode, Errol L. Fields, MD, PhD, MPH, and Armonté Butler, MPH, a pre-exposure prophylaxis (PrEP) advocate, discuss strategies for overcoming barriers to uptake of PrEP for HIV in adolescents and young adults, based on the unique needs of this patient population. Topics covered include: Methods for building trust between patients and provi…
  continue reading
 
During the 2023 American Association of the Study of Liver Diseases (AASLD) conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-delta agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholi…
  continue reading
 
During the 2023 American Association of the Study of Liver Diseases (AASLD) conference, exciting and important results from many primary biliary cholangitis (PBC) clinical trials were reported, including 3 late-breaking studies on the PPAR-delta agonist seladelpar, the dual PPAR agonist elafibranor, and the combination of the FXR agonist obeticholi…
  continue reading
 
In this episode, Martin Rios discusses how pre-exposure prophylaxis (PrEP) persistence depends on healthcare professional knowledge, including: Their own experiences with the various PrEP providers they have seen The relief that has come with seeing PrEP providers who are supportive and knowledgeable about the different PrEP options The challenges …
  continue reading
 
In this episode, Meredith Clement, MD, and Whitney C. Irie, MSW, PhD, discuss key considerations for pre-exposure prophylaxis (PrEP) uptake in cisgender women, including: How to incorporate conversations on PrEP during a short clinic visit Helpful resources about PrEP to share with patients Leveraging clinic staff to improve PrEP uptake and persist…
  continue reading
 
In this episode, Brian Slomovitz, MD, MS, FACOG, and Keiichi Fujiwara, MD, PhD, share their thoughts and opinions on seminal data presented at the 2023 IGCS annual meeting for endometrial, ovarian, and cervical cancers, including: Phase III NRG GY018 trial of carboplatin and paclitaxel with or without pembrolizumab followed by pembrolizumab or plac…
  continue reading
 
In this episode, Helen Y. Chu, MD, MPH, shares updates on RSV seasonality, including: Surveillance limitations due to the testing availability in adults Current 2023/2024 season trends, including predictions for other respiratory viruses (eg, influenza, SARS-CoV-2) Considerations for RSV administration RSV vaccine coadministration with influenza an…
  continue reading
 
In this episode, Rick Zimmerman, MD, MPH, FAAFP, discusses RSV vaccines in older adults, including: Breakthroughs in RSV vaccine development RSV vaccine snapshot in older adults FDA-approved RSV vaccines for older adults CDC evidence to recommendations framework for vaccines RSV burden in older populations Benefits and harms of RSV vaccination RSV …
  continue reading
 
In this episode, Angela Branche, MD; Pamela Rockwell, DO, FAAFP; and Richard Zimmerman, MD, MPH, FAAFP, discuss the clinical presentation of RSV in older adults and available diagnostic tests for RSV, including: Comparison of RSV clinical symptoms to influenza and COVID-19, including differentiating symptoms at infection onset RSV disease progressi…
  continue reading
 
In this episode, Samantha V. Hill, MD, MPH, and Eunice E. Radcliff, MD, discuss key considerations for PrEP uptake in adolescents, including: Advice on talking with parents about the importance of adolescents having alone time with their healthcare professionals Maintaining confidentiality when someone is on their parents’ insurance Strategies to i…
  continue reading
 
In this episode, Jean-Michel Molina, MD, PhD, discusses the data and recommendations for considering on-demand PrEP as a strategy to support PrEP persistence and engagement for men who have sex with men, including: Nondaily PrEP options recommended for cisgender men Data from the ANRS IPERGAY study evaluating on-demand FTC/TDF vs placebo in men who…
  continue reading
 
In this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosis, including: Navitoclax (BCL-XL/BCL-2 inhibitor) Pelabresib (BET inhibitor) Imetelstat (telomerase inhibitor) Luspatercept (erythroid maturation agent) Additional strategies Presenter: Jacqueline S. …
  continue reading
 
Should quantitative HBsAg testing be used routinely in clinical practice for patients living with chronic hepatitis B? In this episode, Tatyana Kushner, MD, MSCE, discusses the role of quantitative hepatitis B surface antigen testing in people living with chronic hepatitis B, including: Determination of inactive carrier status Prediction of liver f…
  continue reading
 
Are we treating HBV early enough? Is it time to move the goalposts regarding the timing of treatment initiation? What are the potential benefits of earlier treatment? To answer these questions, Ira M. Jacobson, MD, leads a panel discussion with Tatyana Kushner, MD, MSCE, and Paul Y. Kwo, MD, exploring which patients with HBV we should be treating, …
  continue reading
 
In this episode, Angela Branche, MD; Pamela Rockwell, DO, FAAFP; and Rick Zimmerman, MD, MPH, FAAFP, discuss the burden of RSV in older adults, including: RSV burden throughout life RSV seasonality in the United States Comparative burden and incidence of RSV and influenza in adults aged 65 years or older Cardiopulmonary hospitalizations of long-ter…
  continue reading
 
In this episode, Beatriz Grinsztejn, MD, PhD, discusses the data and recommendations for addressing social determinants as a strategy to support PrEP persistence and engagement for transgender women, including: HIV prevalence among transgender women Data on the PrEP cascade from the PrEParadas study of daily FTC/TDF among transgender women Data fro…
  continue reading
 
In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman provide practical strategies for implementing RSV vaccination into practice, including: Educating older adults on RSV vaccines Providing effective, evidence-based recommendations Shared decision-making Identifying and addressing vaccine hesitancy Proactive strategies in …
  continue reading
 
In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman discuss the latest practical strategies for preventing RSV infection in older adults, including: Role of basic public health precautions Available and emerging vaccines Mechanisms of action, therapeutic targets, and pharmacology Efficacy and safety data FDA approval stat…
  continue reading
 
In this accredited podcast episode, Dr Mary Bridgeman discusses the most important things for pharmacists across all settings to know about RSV infections in patients 60 years of age or older, including: Incidence and prevalence of RSV in older adults, including hospitalization, mortality, epidemiology Seasonality Clinical manifestations Risk facto…
  continue reading
 
In this episode, Aniruddha (Anu) Hazra, MD, and Ofole Mgbako, MD, discuss key considerations for PrEP uptake in transgender individuals and racial and ethnic minority men who have sex with men, including: Data on drug–drug interactions between PrEP options and gender-affirming hormone therapy Contributing factors to inequities in PrEP uptake for Bl…
  continue reading
 
In this episode, Ana Marin-Niebla, MD, PhD, and Stephan Stilgenbauer, MD, discuss key trial data on the use of BTK inhibitors in CLL and MCL throughout the past year, how these studies have impacted their practice, and what data they are looking forward to in the near future. The discussion includes analyses of: SHINE: First-Line Ibrutinib + Bendam…
  continue reading
 
In this episode, Isabelle Ray-Coquard, MD, PhD, and Ana Oaknin, MD, PhD, provide expert insights on new clinical trial data presented at the 2023 ESMO annual congress for endometrial, ovarian, and cervical cancers, including: Results from the double-blind, randomized, placebo-controlled phase III AtTEnd trial of atezolizumab plus carboplatin/paclit…
  continue reading
 
Despite the season or destination, safety should always be a critical part of your travel plans. From planning and preparation all the way to hotel precautions and communication procedures, we’ll review timely and relevant tips for a safe and healthy trip. Released: November 16, 2023 File Size:  3.8 MB Length:  7:23 minutes…
  continue reading
 
Loading …

מדריך עזר מהיר